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Mitochondria participate in apoptosis through a range of mechanisms that vary between vertebrates and
invertebrates. In vertebrates, they release intermembrane space proteins, such as cytochrome c, to promote
caspase activation in the cytosol. This process is the result of the loss of integrity of the outer mitochondrial
membrane caused by proapoptotic members of the Bcl-2 family. This event is always accompanied by
a fissioning of the organelle. Fission of mitochondria has also been reported to participate in apoptosis in
Drosophila and Caenorhabditis elegans. However, in these organisms, mitochondrial membrane permeabi-
lization does not occur and the mechanism by which mitochondrial dynamics participates in cell death
remains elusive.Introduction
Mitochondria are essential organelles because they supply the
cell with metabolic energy in the form of ATP generated by
oxidative phosphorylation. In addition they perform a number
of other key metabolic reactions. Their shape, from spherical
to elongated, is continually remodeled by fusion and fission
events that link all the organelles within a cell into a continuum
over time. Although why mitochondria are so dynamic is not
known, the process is essential for mitochondrial maintenance
in yeast (Hoppins et al., 2007) and mammals (Chen et al.,
2003). Recently, mitochondrial fission has been linked to the
cellular death program of apoptosis. Mitochondria are involved
in the so-called intrinsic pathway of apoptosis where they
release soluble proteins, including cytochrome c, from the inter-
membrane space to initiate caspase activation in the cytosol
(Kroemer et al., 2007; Vaux, 2011). The release of these proteins
is a consequence of the integrity of the mitochondrial outer
membrane (OMM) being compromised, a process called mito-
chondrial outer membrane permeabilization (MOMP). So far,
this process has only been validated in vertebrates; it does not
seem to be required in C. elegans and is debated in Drosophila.
As reviewed here, in these invertebrates, mitochondria may be
involved in apoptosis through distinct mechanisms. In verte-
brates, MOMP is under the control of the proapoptotic Bcl-2
family members. Here, we will focus on the mechanisms by
which Bcl-2 family members elicit MOMP during apoptosis.
We will also review the link that connects some Bcl-2 family
proteins with fission and fusion of the organelle in apoptosis
and in healthy cells.
Bcl-2 Family Members
Bcl-2 family proteins are subdivided into three groups on the
basis of their pro- or antiapoptotic action and the Bcl-2
Homology (BH) domains they possess (Figure 1A)(Schinzel
et al., 2004; Youle and Strasser, 2008). Antiapoptotic Bcl-2-like
proteins (e.g., Bcl-2, Bcl-xL, Bcl-w, Mcl-1, and A1/Bfl-1) and
proapoptotic Bax-like proteins (e.g., Bax, Bak, and Bok/Mtd)
display four BH domains (Kvansakul et al., 2008). The proapop-92 Developmental Cell 21, July 19, 2011 ª2011 Elsevier Inc.totic BH3-only proteins (e.g., Bid, Bim/Bod, Bad, Bmf, Bik/Nbk,
Blk, Noxa, Puma/Bbc3, and Hrk/DP5), on the other hand,
possess only a short motif called the BH3 domain as their
name indicates. BH3 proteins integrate and transmit death
signals that emanate from defective cellular processes to other
Bcl-2 family members. Through their BH3 domain, these pro-
teins either interact with antiapoptotic proteins to inhibit their
function and/or to interact directly with multidomain proteins
such as Bax or Bak to stimulate their activity. The former are
often referred to as ‘‘sensitizers,’’ whereas the later are classified
as ‘‘activators’’ (reviewed in Giam et al., 2008). The multidomain
proapoptotic proteins, Bax and Bak, and perhaps Bok in some
tissues, are responsible for MOMP and are the master effectors
of apoptosis as cells lacking Bax and Bak fail to undergo MOMP
and apoptosis in response to many death stimuli (Wei et al.,
2001).
Mechanisms of Activation of Proapoptotic Bcl-2 Family
Members
Activation of the proapoptotic Bcl-2 family protein Bax results
from a highly regulated multistep process involving its transloca-
tion from the cytosol to the OMM where it inserts and oligomer-
izes. In contrast to Bax, Bak is constitutively inserted in the OMM
by a C-terminal transmembrane domain. Its insertion can be
facilitated by the voltage-dependent anion channel isoform 2
with which it was found to interact (Cheng et al., 2003; Lazarou
et al., 2010; Roy et al., 2009). In this section, we will describe
what maintains Bax in the cytosol in healthy cells and how
BH3-only proteins, together with the lipid bilayer, cooperate to
promote oligomerization of Bax and Bak in the OMM during
apoptosis.
Bax Travels Back and Forth from the Cytosol to the OMM
in Healthy Cells
In healthy cells, Bax is mainly cytosolic with a minor fraction
loosely attached tomitochondria. In contrast to what is observed
in cultured cells, the amount of membrane-bound Bax is negli-
gible in tissues such as liver or brain. This suggests that themito-
chondrial sub-population of Bax at the mitochondria could be
Figure 1. Structure of Bcl-2 Family Proteins
(A) The Bcl-2 family is divided into three groups
based on their Bcl-2 Homology domains (BH).
Pro- and antiapoptotic proteins contain 4 BH
domains, while BH3-only proteins, as their name
indicates, contain only the BH3 domain.
(B) Structure of Bax showing the a helix 9 (trans-
membrane domain) embedded in the hydrophobic
groove (left structure). A 180 rotation (structure on
the right) shows the a helices 1 and 6. The red
circle represents the binding site for the Bim BH3
domain.
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increases with in vitro culture. Using fluorescence loss in photo-
bleaching, Edlich et al. (2011) observed that Bax constantly
travels back and forth from the cytoplasm to mitochondria
(Figure 2). Once attached to the OMM, it can be retrotranslo-
cated to the cytosol by Bcl-xL by amechanism that is not yet fully
understood. Bax retrotranslocation by Bcl-xL and possibly by
other prosurvival Bcl-2 proteins, would ensure that Bax does
not chronically accumulate at the OMM to reach a critical level
that could promote its autoactivation. It is still unclear what
allows Bax to attach to the OMM specifically in healthy cells.
The most likely explanation is that Bax undergoes discrete and
reversible conformational changes that would expose not only
its BH3 domain but also its N- and C-terminal domains. Consis-
tently, it was previously observed that during detachment of cells
from the extracellular matrix, the N terminus of Bax undergoes
a conformational change that can be reversed upon reattach-
ment of cells to substrate (Gilmore et al., 2000). Understanding
what triggers and controls changes in Bax conformation in
healthy cells requires further investigations. A reversible confor-
mational change in Bax could be induced by a simple contact of
the protein with the lipid bilayer of the OMM, as suggested by
experiments performed with liposomes (Yethon et al., 2003).
Other triggers, including BH3-only proteins, prostaglandins
(Lalier et al., 2011), p53 (Chipuk et al., 2004), pH variations
(Khaled et al., 1999), or posttranslational modifications (Kutuk
and Letai, 2008), all could also be responsible for sending Bax
to the OMM. But what would prevent a complete conformational
change in Bax in healthy cells? The structure of the OMM may
counteract Bax activation. Its cholesterol content has beenDevelopmental Ceshown to prevent Bax insertion or oligo-
merization in the OMM (Christenson
et al., 2008; Lucken-Ardjomande et al.,
2008). Moreover, previous data have
shown that stress-induced mitochondrial
hyperfusion, which leads to highly elon-
gated organelles, delays Bax activation
upon exposure of cells to apoptotic sti-
muli (Tondera et al., 2009). Thus, the lipid
content and the shape of the OMM may
be refractory to complete Bax activation
in healthy cells.
The Role of BH3-Only Proteins
and of the Lipid Bilayer
The protein tBid has been originally
described as a direct activator of Bax,able to induce a conformational change of the Bax N terminus,
as well as modulate Bax insertion and oligomerization in the
OMM (Desagher et al., 1999; Eskes et al., 2000). Many groups
have confirmed and extended these observations to other
BH3-only proteins, including Bim and Puma (Gallenne et al.,
2009; Kim et al., 2009; Kuwana et al., 2005; Me´rino et al., 2009;
Ren et al., 2010). Importantly, these studies have also provided
details about the mechanisms by which BH3-only proteins
trigger conformational changes in Bax, leading to its insertion
and oligomerization in theOMM.Most BH3-only proteins, except
Bid, appear to be intrinsically unstructured proteins. However,
their BH3 domain is known to form an a helix upon binding to
the hydrophobic groove that is on the surface of antiapoptotic
proteins. In Bax, this hydrophobic groove is occupied by a helix
9 (the transmembrane domain) (Figure 1B). Until recently, it was
unclear where BH3 activators impact Bax to induce the structural
changes required for its insertion and assembly in the OMM. To
answer this question, Walenski and colleagues used peptides
whose a helicity was stabilized by a chemical modification
termed ‘‘hydrocarbon stapling.’’ They derived staple peptides
from the BH3 domain of Bid or Bim and reported the first
evidence of a direct interaction between the BH3 domain of
Bim and Bid with Bax (Gavathiotis et al., 2008; Walensky et al.,
2006). Moreover, consistent with previous data (Cartron et al.,
2004), their studies localized the binding site of the BH3 domain
of Bim to the junction of a helices 1 and 6 on the N-terminal side
of Bax, i.e., on the opposite side of the hydrophobic groove (Gav-
athiotis et al., 2008) (Figure 1B). Thus, BH3-only proteins appear
to interact with different sites in Bax and in prosurvival Bcl-2
proteins in which the hydrophobic groove is the receivingll 21, July 19, 2011 ª2011 Elsevier Inc. 93
Figure 2. Bax Moves Back and Forth from the Cytosol to the
Mitochondrial Outer Membrane
In healthy cells, Bax (blue) and Bclx-L (red) are translocated from the cytosol to
the outer mitochondrial membrane (OMM) where they attach loosely. The
triangle in Bax represents its BH3 domain, which needs to be exposed in order
for Bcl-xL-mediated retrotranslocation to occur. OMM: outer mitochondrial
membrane.
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upon interaction with Bim, Bax structural metamorphosis begins
with the displacement of its a helices 1 and 2 from a closed to an
open position, which leads to the release of the a helix 9 from the
hydrophobic groove and exposure of the BH3 domain (Gavathio-
tis et al., 2010). Whether the results obtained with peptides in
solution in these studies faithfully reflect what occurs in the
cell, at the OMM, will require further investigation (discussed in
Czabotar et al., 2009). Moreover, it will be important to clarify
where BH3-only proteins impact Bak, as a previous report
defined the hydrophobic groove as the receiving domain of the
tBid BH3 domain (Moldoveanu et al., 2006).
In contrast to the stapled Bim peptide, tBid is unable to
interact with full-length Bax or Bcl-xL in solution (Lovell et al.,
2008) begging the question of where in the cell do interactions
between BH3-only proteins and Bax or Bak occur. Following
its cleavage by caspase 8, the N terminus of Bid (N-Bid) remains
attached to the C-terminal portion of the protein (C-Bid), possibly
masking the BH3 domain in C-Bid. However, in the presence of
a lipid bilayer with a phospholipid composition mimicking that of
the OMM, it was shown that only C-Bid inserts while N-Bid
remains in solution (Lovell et al., 2008). Thus, upon interaction
with the membrane, tBid is fully operational to recruit Bax to
the OMM as shown by fluorescence resonance energy transfer
(Lovell et al., 2008). These results emphasize the importance of
the lipid environment for activation of these Bcl-2 proteins
and prompted Andrews and colleagues to propose the ‘‘mem-
brane-embedded together’’ model. According to this model,
tBid first inserts in the membrane, then recruits Bax that in turn
inserts and oligomerizes. According to these authors, Bcl-xL
and possibly other antiapoptotic proteins such as Bcl-w that
are in part cytosolic, are also recruited and activated at the
membrane by both the activator and sensitizer BH3-only
proteins (Shamas-Din et al., 2011). This part of themodel confers94 Developmental Cell 21, July 19, 2011 ª2011 Elsevier Inc.on BH3-only proteins an ambiguous role since, in theory, they
could recruit both pro- or antiapoptotic proteins. If this is the
case, and if the role of antiapoptotic Bcl-2 proteins in the OMM
is to prevent Bax or Bak oligomerization, then BH3-only proteins
should be classified as antiapoptotic proteins, which is not
consistent with their known function. Therefore, it is unlikely
that the BH3-only proteins recruit antiapoptotic Bcl-2 family
members into the OMM to inhibit Bax or Bak function. Rather,
BH3-only proteins may recruit antiapoptotic proteins and remain
tightly bound to them to inhibit their function. Soluble and
membrane bound antiapoptotic Bcl-2 proteins could therefore
be inhibited either in the cytosol or at the membrane level by
soluble or membrane-associated BH3-only proteins, respec-
tively. Moreover, antiapoptotic Bcl-2 proteins, whether constitu-
tively present in membranes (such as Bcl-2), or cytosolic (such
as Bcl-xL and Bcl-w), have the possibility to directly interact
with the BH3-only domain of Bax or Bak during the process of
their oligomerization. This implies that the affinity of antiapop-
totic proteins for the BH3 domain of Bax or Bak must be very
high to compete with other Bax or Bak molecules and prevent
their homo-oligomerization.
Is the Lipid Composition of the Membrane Crucial
for tBid-Induced Bax Oligomerization?
Using liposomes containing phosphatidylcholine and phosphati-
dylglycerol, it was previously found that tBid can recruit Bax to
the membrane and drive formation of small pores that could
allow passage of small molecules (such as carboxyfluorescein)
but were impermeable to cytochrome c (Roucou et al., 2002).
Analysis of the quaternary structure of Bax revealed that the
protein was monomeric under this condition. At the same time,
Kuwana et al. (2002) and later others (Lucken-Ardjomande
et al., 2008; Terrones et al., 2004), reported that cardiolipin is
required for the formation of tBid-induced Bax oligomers and
of giant pores. Thus, the presence of cardiolipin in themembrane
appears to promote tBid-induced Bax oligomerization and
formation of cytochrome c-permeable pores. Cardiolipin is a
negatively charged phospholipid, exclusively found in mitochon-
dria, mainly in the IMM where it is important for the activity of
several complexes of the respiratory chain and of some trans-
porters (Hasler, 2011; Schlame et al., 2000; Schug and Gottlieb,
2009). Subfractionation of the mitochondrial membranes, to-
gether with the accessibility of cardiolipin to enzymatic degrada-
tion by Phospholipase 2 added to isolated mitochondria, indi-
cate that small amounts of this phospholipid are also present
in the OMM, probably enriched at contact sites between the
OMM and the IMM (Ardail et al., 1990; Daum, 1985; Epand
et al., 2007; Gebert et al., 2009; Hovius et al., 1990). tBid was
found to bind cardiolipin through central a helices, which would
explain its recruitment to mitochondria, principally at contact
sites between the IMM and the OMM (Kim et al., 2004; Lutter
et al., 2000). In addition to promoting membrane insertion of
tBid, cardiolipin could be involved in the Bax oligomerization
process itself as suggested by the experiment described above
(Roucou et al., 2002). Besides cardiolipin, Gross and colleagues
recently identified MTCH2/MIMP, a protein similar to mitochon-
drial carriers of the adenine nucleotide translocator family, as
a receptor for tBid (Zaltsman et al., 2010). In the absence of
this protein, tBid is recruited less efficiently to the OMM and
apoptosis is delayed when cells are exposed to tBid-dependent
Box 1. Dynamin-Related Proteins Involved in the Fusion and
Fission Mitochondrial Machineries
(1) Drp1 is a large GTPase of the dynamin family that is
required for mitochondrial fission. The protein is cytosolic
and translocates to the mitochondria where it binds to
receptors such as Mff and Fis1. It assembles into rings
around mitochondria and constricts and breaks down
their membrane by a mechanism that is not completely
understood.
(2) Mitofusins: two mitofusins (Mfn), Mfn1, and Mfn2, are
required in the fusion of the outer mitochondrial
membrane. These proteins are integrated in the OMM,
facing the cytosol, and mediate the docking of mitochon-
dria to one another during fusion by engaging in trans-
homo-oligomeric and hetero-oligomeric complexes.
(3) Opa1 (Optic atrophy 1): As its name implies, this protein
was found to be mutated in the disease dominant optic
atrophy, which leads to degeneration of the optic nerve.
Opa1 is required for fusion of the inner mitochondrial
membrane. Different isoforms of this protein that form
a complex integrated in the IMM, facing the intermem-
brane space of mitochondria, have been identified.
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recruitment of tBid to the OMM and may cooperate with cardio-
lipin to provide the OMM with an optimal concentration of tBid.
Further experiments, in particular, using proteoliposomes
preparedwith recombinantMTCH2/MIMP, are required to deter-
mine how tBid binds this carrier protein. Moreover, whether car-
diolipin is needed for Bax activation and MOMP in the cell
requires further investigation as several reports have shown
that this phospholipid can be dispensable for Bax activation
under some conditions (Gonzalvez et al., 2008; Iverson et al.,
2003; Polcic et al., 2005). Importantly, in most studies using lipo-
somes, the process of Bax oligomerization induced by tBid does
not appear to be optimal as only a small fraction of Bax oligomer-
izes, evenwhen high concentrations of tBid are used and despite
the presence of cardiolipin in membranes (Kuwana et al., 2002;
Schafer et al., 2009). This suggests that, in vitro, either important
components that facilitate Bax insertion and/or oligomerization
are missing or that the lipid bilayer structure in these experi-
mental setups is not optimal to allow efficient Bax oligomeriza-
tion.
The Role of Mitochondrial Fission
Mitochondria are dynamic organelles that fuse and divide
continuously. The core components of the fusion and fission
machineries have been identified as the dynamin-related pro-
teins Drp1, mitofusins (Mfn) 1 and 2, and Opa1 (Box 1) (reviewed
in Westermann, 2010). Fission of mitochondria is a constant in
apoptosis (Figure 3) (Martinou and Youle, 2006). The mechanism
underlying this event appears to involve Drp1, the most down-
stream component of the fission machinery (Frank et al., 2001).
The precise mechanism by which Drp1 is recruited to the mito-
chondria during apoptosis remains vague. Under normal condi-
tions, Drp1 moves back and forth from the cytosol to the OMM.
Following Bax activation, Drp1 stably associates with the
OMM due to Bax/Bak-dependent SUMO modification (Wasiak
et al., 2007). However, the mechanistic link between activation
of Bax or Bak and Drp1 SUMOylation is still missing. Importantly,
it should be mentioned that inhibition of Drp1, delays, but does
not completely prevent, mitochondrial fission (Ishihara et al.,
2009). This suggests that a Drp1-independent mechanism also
seems to participate in the fission of the organelle during
apoptosis. A link between mitochondrial fission and Bax activa-
tion was suggested by the detection of active Bax in discrete foci
at mitochondrial fission sites (Karbowski et al., 2002). Bak, which
initially surrounds the organelle, also coalesces into foci at mito-
chondrial fission sites during apoptosis. Inmost cases, (although
not always), these foci appear to be located in proximity to Drp1
and Mfn2 and form independently of Drp1 activity (Frank et al.,
2001; Ishihara et al., 2009; Montessuit et al., 2010). By inhibiting
Drp1 and delaying mitochondrial fission, Karbowski et al. (2002)
could observe these Bax spots at the surface of elongated mito-
chondria. Interestingly, some of them were located at constric-
tion sites that the authors described as ‘‘aberrant mitochondrial
scission attempts.’’ This observation further supports the exis-
tence of a Drp1-independent mechanism responsible for con-
stricting, and possibly fissioning, the organelle during apoptosis.
Such constriction sites have also been observed in healthy Drp1-
deficient cells, not only on mitochondria (Ishihara et al., 2009),
but also on peroxisomes, which rely on Drp1 for division (Koch
et al., 2004). These sites may provide the appropriate membranecurvature, or lipid composition, for the assembly of Drp1 rings
and the formation of Bax foci during apoptosis.
Itwas recently foundthat the formationofmembranehemifusion
intermediates is a process able to promote tBid-inducedBax olig-
omerization (Montessuit et al., 2010). This membrane remodeling
can be promoted by Drp1 in a cell free system and may recapitu-
late the membrane remodeling that occurs at mitochondrial
fission sites in cells undergoing apoptosis (Figure 3). When mem-
branes divide or fuse, contacting leaflets fuse to form a stalk. The
stalk then expands to form a metastable nonbilayer membrane
intermediate also called hemifission or hemifusion intermediate
for membrane fission and fusion respectively (Chernomordik and
Kozlov, 2008; Kozlovsky and Kozlov, 2003). For fusion, this tran-
sient state would evolve toward the formation of a fusion pore,
while for membrane fission it would decay spontaneously into
twoseparatemembranes, therebycompleting thefissionprocess.
The mechanism by which these membrane intermediates pro-
moteBaxoligomerization isstill unclear.Hemifusionorhemifission
intermediates are expected to occur during fusion or fission of the
organelle, respectively. These structures may also possibly form
at contact sites between the OMM and the IMM, which are en-
riched in cardiolipin and phosphatidylethanolamine, two phos-
pholipids that have a propensity to form nonbilayer structures
(Figure 3). The limited number of such membrane structures at
the surfaceofmitochondriamayexplainwhyBaxorBaxoligomers
are not randomly distributed in the OMM in apoptotic cells.
How Does Bax or Bak Permeabilize the Outer
Mitochondrial Membrane?
The mechanism by which Bax, or Bak, permeabilizes mem-
branes to allow efflux of large proteins is still unclear, although
several models having been proposed and challenged. These
models predict that Bax, alone or combined with other proteins,
forms channels large enough to allow passage of cytochrome cDevelopmental Cell 21, July 19, 2011 ª2011 Elsevier Inc. 95
Figure 3. Model for Bax Activation andMitochondrial OuterMembrane Permeabilization: TheRole ofMembraneHemifission andHemifusion
Intermediates
(A) During apoptosis, Drp1 and Bax are recruited to mitochondrial foci. As a result MOMP occurs concomitantly with mitochondrial fission. The release of
cytochrome c promotes caspase activation in the cytosol.
(B) A magnification of what occurs at the level of mitochondrial fission sites. According to the ‘‘embedded together model,’’ tBid first inserts in the outer mito-
chondrial membrane (OMM) to expose its BH3 domain. Upon interaction with the Bid BH3 domain, Bax is, in turn, recruited to the OMM where it inserts and
oligomerizes. This process does not occur randomly at the OMM surface. Bax mainly oligomerizes at mitochondrial fission sites and at contact sites between the
OMM and the IMM.
(C) (Left) A detailed structure of the hemifission intermediate that forms before fission of the organelle. Themembrane forms a nonbilayer structure that represents
a privileged site for the formation of a membrane hole. Upon its oligomerization in the OMM, Bax forms a lipidic pore or triggers the formation of a hole at the edge
of the hemifission intermediate. (Right) A detailed structure of the membrane at OMM and inner mitochondrial membrane (IMM) contact sites. The model
postulates that Bax forms a pore in the membrane at the edges of membrane hemifusion intermediates that may form between the OMM and the IMM.
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opening of existing channels such as the so-called permeability
transition pore, to induce MOMP. However, opening of the
permeability transition pore has been questioned by a number
of genetic studies that have excluded the requirement of some
of its major components (reviewed in Tait and Green, 2010;
Westphal et al., 2011). It is therefore unlikely that the permeability
transition pore plays a role in Bax and Bak-induced MOMP.
Proteinaceous or Lipidic Pores
The model of Bax or Bak pore formation finds its roots in the
determination of the 3D structure of Bcl-xL (Muchmore et al.,
1996). This protein exhibits a structural similarity to bacterial96 Developmental Cell 21, July 19, 2011 ª2011 Elsevier Inc.pore-forming toxins, certain colicins, and the translocation
domain of diphtheria toxin. Other members of the Bcl-2 family
were later determined to have a similar structure. Consistent
with this structural resemblance, Bax and Bcl-2 were found to
form pores in planar lipid bilayers (Antonsson et al., 1997; Schle-
singer et al., 1997). The ability of Bax and Bak to induce MOMP
seems to reside at least in part in the nature of their central
a helices 5 and 6. Thus, replacing the a helix 5 of Bcl-xL by the
equivalent in Bax is sufficient to turn Bcl-xL into a ‘‘killer’’ protein
(George et al., 2007). In addition, differences in the ability of pro-
and antisurvival proteins to oligomerize could explain their
capacity to induce MOMP. Biochemical data support a model
Box 2. Proteinaceous versus Lipidic Pores
Many toxins are known to spontaneously induce transmem-
brane pores in lipid bilayers under certain conditions. Depend-
ing on their structure, they can form either proteinaceous or
lipidic pores (Yang et al., 2001).
Proteinaceous pores (also called barrel-stave pores): toxins
form a barrel-like pore that spans the membrane. The pore
lumen is lined by peptides that are perpendicularly inserted
in the membrane.
Lipidic pores (also called toroidal pores): insertion of the
peptides in the membrane triggers lipid monolayer bending
such that the outer and inner leaflets of the membrane are
continuous. The pore is lined by both the peptides and the lipid
head groups.
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involving the BH3:groove and a helix 6: a helix 6 interfaces, while
a helices 5, 6, and 9 are embedded in the membrane (Dewson
et al., 2008; Zhang et al., 2010). Although a model for Bax or
Bak oligomerization is beginning to emerge, the atomic details
of membrane-embedded Bax and Bak oligomer are still missing.
In particular, the number of units present in the Bax or Bak oligo-
mers remains elusive and estimates vary considerably depend-
ing on the approaches used. Assessing the minimal size of the
Bax or Bak oligomer that is responsible for MOMP is critical,
but difficult. Indeed, once oligomerization has been initiated,
self-oligomerization proceeds which may lead to the recruitment
of hundreds of Bax molecules, which then protrude out of the
OMM (Nechushtan et al., 2001b). Whether all these molecules
are required for pore-formation in the membrane is questionable
(Du¨ssmann et al., 2010). Such heterogeneity of oligomers may
hamper resolution of the 3D structure of these proteins within
a membrane. Moreover, the nature of the pore formed by
Bax—whether proteinaceous or lipidic (Box 2)—is still under
debate. Although some reports favor formation of a proteina-
ceous channel (Dejean et al., 2005; Epand et al., 2002), other
results are consistent with formation of a lipidic pore (Basan˜ez
et al., 1999; Garcı´a-Sa´ez et al., 2007; Garcı´a-Sa´ez et al., 2006).
In favor of the latter model, a helix 5 of Bax, which is sufficient
to perforate membranes, was found to form lipidic pores in
a synthetic membrane by X-ray diffraction (Qian et al., 2008).
However, onemustbecautiouswithoverall structural predictions
of Bax based on data obtained with only minimal domains of the
protein. Nevertheless, there are other reasons to favor the lipidic
pore model for Bax and Bak. Recently, analysis of Bax-permea-
bilized liposomes by cryoelectron microscopy revealed large
openings of the membrane, from 25 to 100 nm, compatible with
the release of megadalton dextrans. Importantly, the edges of
these pores were devoid of protein (Bleicken et al., 2010; Schafer
et al., 2009).Whether pores of this type are formed in theOMMof
mitochondria undergoing MOMP remains now to be shown.
Mechanistic Link between Mitochondrial Dynamics
and MOMP: The Role of Membrane Hemifusion/
Hemifission Intermediates
The notion that MOMP and mitochondrial fission are mechanis-
tically linked remains controversial. In some reports, inhibition ofmitochondrial fission or stimulation of fusion, significantly de-
layed apoptosis (Cassidy-Stone et al., 2008; Frank et al., 2001;
Germain et al., 2005; Merrill et al., 2011). Puzzlingly, cells from
the neural crest failed to die in Drp1-knockout mouse embryos
(Wakabayashi et al., 2009), whereasmouse embryonic fibroblast
cell lines generated from these Drp1-deficient mice displayed
little (Wakabayashi et al., 2009) or partial (Ishihara et al., 2009)
resistance to apoptosis. In other studies, inhibitingmitochondrial
fission in HeLa cells had no or only a minor impact on the kinetics
of MOMP and cell death (Estaquier and Arnoult, 2007; Ishihara
et al., 2009; Parone et al., 2006; Sheridan et al., 2008). Moreover,
some studies showed that it was possible to dissociate mito-
chondrial fission from MOMP. James et al. (2003) reported that
Bcl-xL could inhibit MOMP and apoptosis due to overexpression
of the putative Drp1 receptor hFis1, without preventing Fis-1-
induced fission. On the other hand, Sheridan et al. (2008)
observed that Bcl-xL, as well as other members of the apo-
ptosis-inhibitory subset of the Bcl-2 family, antagonized Bax
and/or Bak-induced cytochrome c release but failed to block
mitochondrial fragmentation associated with Bax/Bak activa-
tion. Several studies also reported that inhibition of mitochon-
drial fission did not prevent the efflux of Smac/DIABLO, a protein
present in the intermembrane space of mitochondria, although it
could delay cytochrome c release (Estaquier and Arnoult, 2007;
Parone et al., 2006). These data favor a model in which mito-
chondrial fission inhibition could retard cytochrome c release
by preventing the remodeling of mitochondria cristae, a process
that is thought to be required for efficient cytochrome cmobiliza-
tion (Cipolat et al., 2006; Yamaguchi et al., 2008). Re-evaluation
of these conflicting data, in particular, in light of the new results
by Montessuit et al. (2010) on the role of mitochondrial mem-
brane hemifusion/hemifission intermediates in Bax oligomeriza-
tion, provides at least two explanations for why inhibiting Drp1
can only delay cytochrome c release and cell death. First, this
is because the inhibition of known components of the mitochon-
drial fission machinery cannot completely prevent mitochondrial
fission as previously mentioned. Second, this is because it
appears that rather than the fission of mitochondria per se, it is
the formation of membrane hemifission intermediates that may
play a central role in Bax oligomerization and MOMP. According
to theoretical studies, a place where the cost in energy to form
amembrane hole would beminimal is at the edge of amembrane
hemifusion structure (Katsov et al., 2004). The observation that
Bax is confined at discrete foci at the surface of mitochondria,
some of which coincide with mitochondrial fission sites, together
with the new role of membrane hemifusion or hemifission inter-
mediates in the oligomerization of Bax during apoptosis, raise
the possibility that Bax may opportunistically target those sites
that are optimally designed for it to oligomerize and to perforate
the membrane (Figure 3).
The Role of Mitochondria in Drosophila Cell Apoptosis
Steps of apoptosis upstream of caspases are regulated differ-
ently in flies andmammals (Salvesen andAbrams, 2004). Indeed,
the role of Bcl-2 family members in Drosophila in apoptosis is
relatively minor (Sevrioukov et al., 2007). In contrast, the Hid/
Grim/Reaper gene products that derepress the IAP proteins
that block caspases through the ubiquitin proteosome pathway
are potent inducers of fly cell apoptosis (Bader and Steller,Developmental Cell 21, July 19, 2011 ª2011 Elsevier Inc. 97
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processes to Hid, Grim, and Reaper, as well as to the Bcl-2
family members Buffy and DEBCL and to apoptosis. As dere-
pressors of cytosolic IAP, there had been no explanation why
Hid (Haining et al., 1999), Grim (Claverı´a et al., 2002), and Reaper
(Olson et al., 2003) localize to mitochondria until recent work has
linked Reaper to the mitochondrial fusion machinery. Although
caution should be taken in interpreting these results due to the
expression in heterologous cells of fly proteins that lack known
mammalian homologs, Reaper expressed in HeLa cells localizes
to the OMM and inhibits mitochondrial fusion inducing mito-
chondrial fragmentation. Reminiscent of mammalian proapop-
totic Bcl-2 family members (Nechushtan et al., 2001a), Reaper
forms concentrated foci on mitochondria (Thomenius et al.,
2011). Overexpression in HeLa cells of Mfn2, a dynamin family
member that mediates mitochondrial fusion, changes Reaper
localization from foci to more evenly coat mitochondria suggest-
ing they interact, consistent with data that a peptide of Reaper
can coimmunoprecipitate with Xenopus Mfn2 (Thomenius
et al., 2011). Mitochondrial localization, mitochondrial fragmen-
tation activity and Mfn2 interaction required the GH3 domain of
Reaper indicating that Reaper binds Mfn2 on mitochondria
through the GH3 domain that is needed to induce apoptosis
(Thomenius et al., 2011). Alternatively or additionally, mitochon-
drial Hid may recruit Reaper to mitochondria (Sandu et al., 2010).
Interestingly, mitochondrial Reaper and Hid can recruit IAPs to
mitochondria where they may induce IAP autoubiquitination
and proteosomal degradation. Mitochondria fragment during
apoptosis in Drosophila (Goyal et al., 2007; Abdelwahid et al.,
2007) possibly through Reaper interaction with mitofusin and
inhibition of mitochondria fusion (Thomenius et al., 2011). Pre-
venting this mitochondrial fragmentation by inhibition of Drp1
prevents death of fly cells in vitro and in vivo (Abdelwahid
et al., 2007; Goyal et al., 2007).
Apoptosis in the Worm
CED-9, the sole multidomain Bcl-2 family member in C. elegans,
is localized to the mitochondria (Chen et al., 2000). Although it
primarily inhibits apoptosis through the binding and sequestra-
tion of the caspase activator, CED-4, CED-9 can promote apo-
ptosis in weak loss of function CED-3 caspase mutants (Hen-
gartner and Horvitz, 1994). As in mammalian and Drosophila
cells, mitochondria fragment in the worm during apoptosis and
this fragmentation is dependent on CED-9 and the BH3-only
protein, EGL-1 (Jagasia et al., 2005). Although there is no
evidence of cytochrome c release or MOMP in the worm, inhibi-
tion of mitochondrial fragmentation by expression of a dominant
negative inhibitor of Drp1 prevents 20% of the normal develop-
mental cell death in C. elegans (Jagasia et al., 2005).
Bcl-2 Family Proteins and Mitochondrial Dynamics
The link between mitochondrial fission and apoptosis has been
further strengthened by several studies that show Bcl-2 family
members alter mitochondrial dynamics even in healthy cells
(Delivani et al., 2006; Karbowski et al., 2006; Rolland et al.,
2009; Tan et al., 2008). Overexpression of Bcl-2 family proteins
CED-9 and Bcl-xL can induce mitochondrial fusion in mamma-
lian cells (Delivani et al., 2006) and in C. elegans (Rolland et al.,
2009; Yamaguchi et al., 2008). Bcl-xL can also accelerate mito-98 Developmental Cell 21, July 19, 2011 ª2011 Elsevier Inc.chondrial fission in mammalian neurons thereby accelerating
mitochondrial dynamics (Berman et al., 2009). The proapoptotic
Bax and Bak, although having the opposite effect on cell viability
relative to Bcl-xL, are required for the normal rate of mitochon-
drial fusion in cells (Karbowski et al., 2006). Recent work also
shows that in a cell free system ofmitochondrial fusion, recombi-
nant Bax can stimulate the process specifically through Mfn2
and notMfn1 (Hoppins et al., 2011). Tethering Baxwith disulfides
to hinder conformational change abolishes the mitochondrial
fusion activity indicating that at least subtle conformational
changes are involved. Promotion of mitochondrial fusion may
be a consequence of direct interaction between Bcl-2 family
members and Mfn1/2 (Brooks et al., 2007; Delivani et al., 2006;
Rolland et al., 2009; Cleland et al., 2011) although howmitofusins
may be activated remains unclear. Recent work links Bcl-2
family members to mitochondrial dynamics also in Drosophila,
during fly oogenesis. Loss of the fly Bcl-2 family members, Buffy
and/or DEBCL, disrupts nurse cell death, which occurs after the
nurse cells transfer some of their cytosol and organelles into the
developing oocyte. Buffy and/or DEBCL loss also increases
mitochondrial network formation and mitochondrial clumping
in the surviving cells, suggesting that in certain tissues in the
fly, Bcl-2 family members affect mitochondrial dynamics
upstream of apoptosis (Tanner et al., 2011). Thus, links between
Bcl-2 family members and mitochondrial dynamics have been
identified in mammals, insects, and roundworms. How the
effects of the Bcl-2 family members on mitochondrial dynamics
in healthy cells may relate to mitochondrial fragmentation during
apoptosis (subsequent to Bcl-2 family member conformational
change and insertion into mitochondrial membranes) is an
important question that remains to be resolved.
Concluding Remarks
Over the past decade, our understanding of the mechanism of
action of Bcl-2 family members has expanded significantly.
The 3D structure of many members of the family, in solution,
has been solved and the mechanism by which these proteins
interact is better understood, even though some controversies
remain as to how BH3-only proteins regulate multidomain
Bcl-2 family members. Importantly, the lipid composition and
structural organization of the OMM has emerged as one of the
central players in the regulation of Bcl-2 family member activity.
However, the precise 3D structure that many Bcl-2 proteins
adopt in this membrane is still unknown. Without this essential
information, it is impossible to understand precisely how
MOMP occurs. The challenge for the coming years will be to
solve the structure of membrane-embedded key Bcl-2 family
members and to understand how the lipid composition and
structure of the OMM controls activation of Bcl-2 family mem-
bers and MOMP.
Recent work from several laboratories has also unraveled new
functions for many pro- and antiapoptotic members of the Bcl-2
family, besides their role in apoptosis. Although our review has
been focused on the involvement of Bcl-2 family members in
mitochondrial dynamics, it is clear that these proteins play addi-
tional roles in other cellular processes. These functions, and new
ones that may be discovered in the future, will certainly help
decipher the complex role Bcl-2 family members play in life
and death of the cell.
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